Genpact Limited
G
$42.21
$0.421.01%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.93B | 4.85B | 4.77B | 4.66B | 4.59B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.93B | 4.85B | 4.77B | 4.66B | 4.59B |
| Cost of Revenue | 3.17B | 3.13B | 3.08B | 3.01B | 2.97B |
| Gross Profit | 1.76B | 1.72B | 1.69B | 1.65B | 1.62B |
| SG&A Expenses | 997.41M | 975.26M | 969.21M | 957.13M | 943.54M |
| Depreciation & Amortization | 21.63M | 23.87M | 26.48M | 27.43M | 28.44M |
| Other Operating Expenses | -233.00K | -262.00K | -4.12M | -4.11M | -4.18M |
| Total Operating Expenses | 4.19B | 4.13B | 4.07B | 3.99B | 3.93B |
| Operating Income | 737.47M | 723.72M | 698.50M | 671.40M | 655.44M |
| Income Before Tax | 710.00M | 695.68M | 676.82M | 652.75M | 632.16M |
| Income Tax Expenses | 171.69M | 168.10M | 163.15M | -10.32M | -15.68M |
| Earnings from Continuing Operations | 538.30 | 527.58 | 513.67 | 663.06 | 647.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 538.30M | 527.58M | 513.67M | 663.06M | 647.84M |
| EBIT | 737.47M | 723.72M | 698.50M | 671.40M | 655.44M |
| EBITDA | 826.29M | 814.90M | 792.65M | 766.87M | 752.02M |
| EPS Basic | 3.06 | 2.98 | 2.88 | 3.68 | 3.59 |
| Normalized Basic EPS | 2.52 | 2.46 | 2.37 | 2.27 | 2.18 |
| EPS Diluted | 3.01 | 2.93 | 2.84 | 3.64 | 3.54 |
| Normalized Diluted EPS | 2.48 | 2.42 | 2.34 | 2.24 | 2.16 |
| Average Basic Shares Outstanding | 703.62M | 708.66M | 713.54M | 718.62M | 722.42M |
| Average Diluted Shares Outstanding | 714.39M | 718.25M | 721.75M | 725.92M | 730.01M |
| Dividend Per Share | 0.65 | 0.63 | 0.61 | 0.60 | 0.58 |
| Payout Ratio | 21.00% | 20.99% | 21.12% | 16.07% | 16.14% |